Brightspire Capital Inc
F:41W0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Brightspire Capital Inc
F:41W0
|
US |
|
Cogent Communications Holdings Inc
NASDAQ:CCOI
|
US |
|
Bank Central Asia Tbk PT
IDX:BBCA
|
ID |
|
Bank Central Asia Tbk PT
OTC:PBCRY
|
ID |
|
T
|
Ternium SA
F:T5Z
|
LU |
|
T
|
Telefonaktiebolaget LM Ericsson
SWB:ERCB
|
SE |
|
A
|
Aluminum Corporation of China Ltd
BMV:ACHN
|
CN |
|
FibroGen Inc
NASDAQ:KYNB
|
US |
|
A
|
Ageas SA
OTC:AGESY
|
BE |
|
A
|
Ageas SA
MIL:AGS
|
BE |
|
C
|
Cohort PLC
F:C7K
|
UK |
|
A
|
Alnylam Pharmaceuticals Inc
F:DUL
|
US |
|
U
|
UnitedHealth Group Inc
XMUN:UNH
|
US |
|
P
|
PetroChina Co Ltd
DUS:PC6
|
CN |
Wall St Price Targets
41W0 Price Targets Summary
Brightspire Capital Inc
According to Wall Street analysts, the average 1-year price target for 41W0 is 5.69 EUR with a low forecast of 4.76 EUR and a high forecast of 6.3 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41W0's stock price target?
Price Target
5.69
EUR
According to Wall Street analysts, the average 1-year price target for 41W0 is 5.69 EUR with a low forecast of 4.76 EUR and a high forecast of 6.3 EUR.
What is the Revenue forecast for Brightspire Capital Inc?
Projected CAGR
-33%
Over the last 9 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is -33%.
What is the Operating Income forecast for Brightspire Capital Inc?
Projected CAGR
-39%
Over the last 9 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is -39%.
